Cargando…
Current research into A20 mediation of allergic respiratory diseases and its potential usefulness as a therapeutic target
Allergic airway diseases are characterized by excessive and prolonged type 2 immune responses to inhaled allergens. Nuclear factor κB (NF-κB) is a master regulator of the immune and inflammatory response, which has been implicated to play a prominent role in the pathogenesis of allergic airway disea...
Autores principales: | Liu, Yan, Xu, Kai, Yao, Yin, Liu, Zheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086152/ https://www.ncbi.nlm.nih.gov/pubmed/37056760 http://dx.doi.org/10.3389/fimmu.2023.1166928 |
Ejemplares similares
-
Editorial: Mechanisms and advances in respiratory allergic diseases
por: Cheng, Bao-Hui, et al.
Publicado: (2023) -
Current Strategies to Inhibit High Affinity FcεRI-Mediated Signaling for the Treatment of Allergic Disease
por: Gomez, Gregorio
Publicado: (2019) -
Group 2 Innate Lymphoid Cells in Respiratory Allergic Inflammation
por: Helfrich, Sofia, et al.
Publicado: (2019) -
IL33: Roles in Allergic Inflammation and Therapeutic Perspectives
por: Chan, Ben C. L., et al.
Publicado: (2019) -
Current Strategies to Modulate Regulatory T Cell Activity in Allergic Inflammation
por: Bellinghausen, Iris, et al.
Publicado: (2022)